Abstract | BACKGROUND:
Tumors can be targeted by the adoptive transfer of chimeric antigen receptor (CAR) redirected T-cells. Antigen-specific expansion protocols are needed to generate large quantities of redirected T-cells. We aimed to establish a protocol to expand functional active NY-ESO-1-specific redirected human CD8(+) T-cells. MATERIALS AND METHODS: The anti-idiotypic Fab antibody A4 with specificity for HLA-A 0201/NY-ESO-1157-165 was tested by competition assays using a HLA-A 0201/NY-ESO-1157-165 tetramer. HLA-A 0201/NY-ESO-1157-165 redirected T-cells were generated, expanded and tested for CAR expression, cytokine release, in vitro cytolysis and protection against xenografted HLA-A 0201/NY-ESO-1157-165-positive multiple myeloma cells. RESULTS: A4 demonstrated antigen-specific binding to HLA-A 0201/NY-ESO-1157-165 redirected T-cells. Expansion with A4 resulted in 98% of HLA-A 0201/NY-ESO-1157-165 redirected T-cells. A4 induced strong proliferation, resulting in a 300-fold increase of redirected T-cells. After expansion protocols, redirected T-cells secreted Interleukin-2, (IL-2), interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and lysed target cells in vitro and were protective in vivo. CONCLUSION: A4 expanded HLA-A 0201/NY-ESO-1157-165 redirected T-cells with preservation of antigen-specific function.
|
Authors | Gopinadh Jakka, Petra C Schuberth, Markus Thiel, Gerhard Held, Frank Stenner, Maries Van Den Broek, Christoph Renner, Axel Mischo, Ulf Petrausch |
Journal | Anticancer research
(Anticancer Res)
Vol. 33
Issue 10
Pg. 4189-201
(Oct 2013)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 24122982
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- CTAG1B protein, human
- Immunoglobulin Fab Fragments
- Membrane Proteins
|
Topics |
- Animals
- Antibody Affinity
- Antigens, Neoplasm
(immunology)
- CD8-Positive T-Lymphocytes
(immunology, transplantation)
- Cell Line, Tumor
- Cell Proliferation
- Cell-Free System
- Coculture Techniques
- Cytotoxicity, Immunologic
- HEK293 Cells
- Humans
- Immunoglobulin Fab Fragments
(immunology)
- Immunotherapy, Adoptive
- Lymphocyte Activation
- Membrane Proteins
(immunology)
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Multiple Myeloma
(immunology, pathology, therapy)
- Neoplasm Transplantation
- T-Lymphocytes, Cytotoxic
(immunology)
- Tumor Burden
|